The loss of Chembio Diagnostics under GAAP for the 3 months of 2022 was $8.79 million, up 95.3% from $4.5 million in the previous year. Revenue increased 2.2-fold to $18.817 million from $8.724 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept